Functional activity of anti-C6 antibodies elicited in C6-deficient rats reconstituted by liver allografts: Ability to inhibit hyperacute rejection of discordant cardiac xenografts

Transplantation

Volumn 61, Issue 4, 1996, Pages 588-594

  Brauer, Robert B ^a   Baldwin III, William M ^b   Wang, Dajie ^b   Pruitt, Scott K ^c   Klein, Andrew S ^b   Sanfilippo, Fred ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; COMPLEMENT COMPONENT C6; POLYCLONAL ANTIBODY;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ARTICLE; COMPLEMENT DEFICIENCY; CONTROLLED STUDY; GRAFT REJECTION; GUINEA PIG; HEART TRANSPLANTATION; HUMORAL IMMUNITY; LIVER TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; XENOGRAFT;

ANIMALS; ANTIBODIES; ANTIBODIES, MONOCLONAL; ANTIBODY FORMATION; BLOTTING, WESTERN; COMPLEMENT C6; COMPLEMENT HEMOLYTIC ACTIVITY ASSAY; GRAFT SURVIVAL; GUINEA PIGS; HEART TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; RATS; RATS, INBRED LEW; TRANSPLANTATION, HETEROLOGOUS;

EID: 0029975841     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199602270-00013     Document Type: Article

References (36)

1. Reemtsma K. Xenografts. Transplant Proc 1992; 24: 2225.
2. Reemtsma K. Xenografts. Transplant Proc 1989; 21: 517.
3. Platt JL, Vercellotti GM, Dalmasso AP, et al. Transplantation of discordant xenografts: a review of progress. Immunol Today 1990; 11: 450.
4. Leventhal JR, Dalmasso AP, Cromwell JW, et al. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 1993; 55: 857.
5. Cochrane CG, Müller-Eberhard H, Aikin BS. Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions. J Immunol 1970; 105: 55.
6. Adachi H, Rosengard BR, Hutchins GM, Baumgartner WA, Borkon AM, Reitz BA. Effects of cyclosporin, aspirin, and cobra venom factor on discordant cardiac xenograft survival in rats. Transplant Proc 1987; 19: 1145.
7. Pruitt SK, Baldwin WM III, Marsh HC Jr, Lin SS, Yeh CG, Bollinger RR. The effect of soluble complement receptor type 1 on hyperacute xenograft rejection. Transplantation 1991; 52: 868.
8. Xia W, Fearon DT, Kirkman RL. Effect of repetitive doses of soluble human complement receptor type 1 on survival of discordant cardiac xenografts. Transplant Proc 1993; 25: 410.
9. Pruitt SK, Kirk AD, Bollinger RR, et al. The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 1994; 57: 363.
10. Brauer RB, Baldwin WM III, Daha MR, Pruitt SK, Sanfilippo F. Use of C6-deficient rats to evaluate the mechanism of hyperacute rejection of discordant cardiac xenografts. J Immunol 1993; 151: 7240.
11. Kemp E, Dieperink H, Leth P, et al. Monoclonal antibodies to complement C3 prolong survival of discordant xenografts: guinea pig heart to rat transplantation. Transplant Proc 1994; 26: 1011.
12. Baker PJ, Ochi RF, Schulze M, Johnson RJ, Campbell C, Couser WG. Depletion of C6 prevents development of proteinuria in experimental membranous nephropathy in rats. Am J Pathol 1989; 135: 185.
13. Couser WG, Ochi RF, Baker PJ, Schulze M, Campbell C, Johnson RJ. C6 depletion reduces proteinuria in experimental nephropathy induced by a nonglomerular antigen. J Am Soc Nephrol 1991; 2: 894.
14. Brauer RB, Baldwin WM III, Wang D, et al. Hepatic and extrahepatic biosynthesis of complement factor C6 in the rat. J Immunol 1994; 153: 3168.
15. Kamada N, Calne RY. Orthotopic liver transplantation in the rat. Technique using cuff for portal vein anastomosis and biliary drainage. Transplantation 1979; 28: 47.
16. Kamada N, Calne RY. A surgical experience with five hundred thirty liver transplants in the rat. Surgery 1983; 93: 64.
17. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 57: 225.
18. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680.
19. Springer TA, Bhattacharya A, Cardoza JT, Sanchez MF. Monoclonal antibodies specific for rat IgG1, IgG2a, and IgG2b subclasses, and kappa chain monotypic and allotypic determinants: reagents for use with rat monoclonal antibodies. Hybridoma 1982; 1: 257.
20. Whaley K. Measurement of complement. In: Whaley K, ed. Methods in complement for clinical immunologists. Edinburgh: Churchill-Livingstone. 1985: 77.
21. Pruitt SK, Bollinger RR. The effect of soluble complement receptor type 1 on hyperacute allograft rejection. J Surg Res 1991; 50: 350.
22. Brauer RB, Baldwin WM III, Ibrahim S, Sanfilippo F. The contribution of terminal complement components to acute and hyperacute allograft rejection in the rat. Transplantation 1995; 59: 288.
23. Leventhal JR, Dalmasso AP, Cromwell JW, Manivel CJ, Bolman RM III, Matas AJ. Complement depletion prolongs discordant cardiac xenograft survival in rodents and non-human primates. Transplant Proc 1993; 25: 398.
24. Leventhal JR, Matas AJ, Hong Sun L, et al. The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model. Transplantation 1993; 56: 1.
25. Schilling A, Land W, Pratschke E, Pielsticker K, Brendel W. Dominant role of complement in hyperacute xenograft rejection. Surg Gynecol Obstet 1976; 142: 29.
26. Tavakoli R, Michel A, Cardoso J, et al. Prolonged survival of guinea pig-to-rat heart xenografts using repeated low doses of cobra venom factor. Transplant Proc 1993; 25: 407.
27. Hayashi S, Ito M, Yokoyama I, Uchida K, Takagi H. Effectiveness of combination therapy using cobra venom factor, splenectomy, and desoxyspergualin in guinea pig to rat cardiac xenografts. Transplant Proc 1993; 25: 405.
28. Pruitt SK, Baldwin WM III, Barth RN, Bollinger RR, Sanfilippo F. The effect of xenoreactive antibody and B-cell depletion on hyperacute rejection of GP-to-rat cardiac xenograft. Transplantation 1993; 56: 1318.
29. Vogt W. Anaphyltoxins: possible roles in disease. Complement 1986; 3: 177.
30. Yancey KB. Biological properties of human C5a: selected in vito and in vivo studies. Clin Exp Immunol 1988; 71: 207.
31. Braidley PC, Dunning JJ, Wallwork J, White DJ. Prolongation of survival of rat heart xenografts in C3-deficient guinea pigs. Transplant Proc 1994; 26: 1259.
32. Magee JC, Collins BH, Harland RC, Bollinger RR, Frank MM, Platt JL. Prevention of hyperacute xenograft rejection by intravenous immunoglobulin. Transplant Proc 1995; 27: 271.
33. Baldwin WM III, Pruitt SK, Brauer RB, Daha MR, Sanfilippo F. Complement in organ transplantation: contributions to inflammation, injury and rejection. Transplantation 1995; 59: 797.
34. Sekiya S, Gotoh S, Yamashita T, Watanabe T, Saitoh S, Sendo F. Selective depletion of rat neutrophils by in vivo administration of a monoclonal antibody. J Leukoc Biol 1989; 46: 96.
35. Davis EA, Lam TT, Qian Z, Ibrahim S, Baldwin WM III, Sanfilippo FP. Inhibition of neutrophil adhesion and the membrane attack complex of complement synergistically prolongs cardiac xenograft survival. J Heart Lung Transplant 1995; 14: 973.
36. Zehr KJ, Herskowitz A, Lee PC, Kumar P, Gillinov AM, Baumgartner WA. Neutrophil adhesion and complement inhibition prolongs survival of cardiac xenografts in discordant species. Transplantation 1994; 57: 900.